MAPK14 and acute myeloid leukemia: Pretreatment of HL-60 cells with SB203580 significantly reversed EF-24-induced PP2A activation (Figure 5E), suggesting that p38 is an upstream regulator involved in EF-24-induced PP2A activation in AML cells.